Retatrutide's Effect on Hypoglycemia Recovery in Type 2 Diabetes Patients

Type 2 Diabetes Mellitus (T2DM) is a widespread chronic metabolic condition characterized by persistently elevated blood glucose levels, leading to serious long-term complications. While effective glucose-lowering therapies are crucial, a significant and potentially dangerous side effect of some treatments is hypoglycemia, or dangerously low blood sugar, which can cause confusion, seizures, and even coma. This study specifically addresses the critical knowledge gap regarding how once-weekly Retatrutide impacts the physiological response and recovery time from induced hypoglycemia in individuals living with T2DM, aiming to enhance the safety profile assessment of this promising therapeutic agent.